Bellevue Group AG - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$8,338,000
-52.4%
721,9250.0%0.12%
-53.6%
Q2 2020$17,514,000
+120.1%
721,9250.0%0.25%
+61.0%
Q1 2020$7,956,000
-58.3%
721,9250.0%0.15%
-49.2%
Q4 2019$19,080,000
+16.0%
721,9250.0%0.30%
-1.0%
Q3 2019$16,445,000
-20.2%
721,925
+7.4%
0.31%
-13.1%
Q2 2019$20,601,000671,9250.35%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders